Prophylactic Vasopressin in Patients Receiving the Angiotensin-Converting Enzyme Inhibitor Ramipril Undergoing Coronary Artery Bypass Graft Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 2, 2010, Pages 230-238

  Hasija, Suruchi ^a   Makhija, Neeti ^a   Choudhury, Minati ^a   Hote, Milind ^a   Chauhan, Sandeep ^a   Kiran, Usha ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

angiotensin converting enzyme inhibitor; coronary artery bypass graft surgery; hemodynamic; vasoactive; vasopressin

Indexed keywords

RAMIPRIL; VASOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASOPRESSIN DERIVATIVE;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; HEMODYNAMICS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; WARMING; AGED; BLOOD PRESSURE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; HEART RATE; HYPOTENSION; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RAMIPRIL; VASOPRESSINS;

EID: 77950022047     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.08.001     Document Type: Article

References (52)

1. Sutton M.S. Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction?. Perspectives from the Survival and Ventricular Enlargement (SAVE) trial. Br Heart J 71 (1994) 115-118
2. Garg R., and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273 (1995) 1450-1456
3. Raja S.G., and Fida N. Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?. Interact Cardiovasc Thorac Surg 7 (2008) 470-475
4. Coriat P., Richer C., Douraki T., et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 81 (1994) 299-307
5. Augoustides J.G.T. Angiotensin blockage and general anesthesia: So little known, so far to go. J Cardiothorac Vasc Anesth 22 (2008) 177-179
6. Smith M.S., Muir H., and Hall R. Perioperative management of drug therapy, clinical considerations. Drugs 51 (1996) 238-259
7. Ryckwaert F., and Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 84 (1997) 945-949
8. Mirenda J.V., and Grissom T.E. Anesthetic implications of the renin-angiotensin system and angiotensin-converting enzyme inhibitors. Anesth Analg 72 (1991) 667-683
9. Licker M., Neidhart P., Lustenberger S., et al. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology 84 (1996) 789-800
10. Boldt J., Schindler E., Harter K., et al. Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients. Anesth Analg 80 (1995) 480-485
11. Myles P.S., Olenikov I., Bujor M.A., et al. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study. Med J Aust 158 (1993) 675-677
12. Konstam M.A., Rousseau M.F., Kronenberg M.W., et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 86 (1992) 431-438
13. Bottcher M., Behrens J.K., Moller E.A., et al. ACE inhibitor premedication attenuates sympathetic responses during surgery. Br J Anaesth 72 (1994) 633-637
14. Heropoulos M., Schieren H., Seltzer J.L., et al. Intraoperative hemodynamic, renin, and catecholamine responses after prophylactic and intraoperative administration of intravenous enalaprilat. Anesth Analg 80 (1995) 583-590
15. Colson P. Angiotensin-converting enzyme inhibitors. In: Jones R.M., Aitkenhead A.R., and Foex P. (Eds). Clinical Cardiovascular Medicine in Anaesthesia (1997), BMJ Publishing Group, London 52-73
16. Tamayo E., Di Stefano S., Carassiti M., et al. Evaluation of the withdrawal of ACE inhibitors in coronary artery surgery. Clin Ter 155 (2004) 171-174
17. Colson P., Ribstein J., Mimran A., et al. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 72 (1990) 23-27
18. Boldt J., Rothe G., Schindler E., et al. Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?. Heart 76 (1996) 207-213
19. Hock C.E., Ribeiro L.G., and Lefer A.M. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. Am Heart J 109 (1985) 222-228
20. Colson P., Saussine M., Seguin J.R., et al. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 74 (1992) 805-808
21. Yates A.P., and Hunter D.N. Anaesthesia and angiotensin-converting enzyme inhibitors. The effect of enalapril on perioperative cardiovascular stability. Anaesthesia 43 (1988) 935-938
22. Kataja J.H., Kaukinen S., Viinamaki O.V., et al. Hemodynamic and hormonal changes in patients pretreated with captopril for surgery of the abdominal aorta. J Cardiothorac Anesth 3 (1989) 425-432
23. Thaker U., Geary V., Chalmers P., et al. Low systemic vascular resistance during cardiac surgery: Case reports, brief review, and management with angiotensin II. J Cardiothorac Anesth 4 (1990) 360-363
24. Argenziano M., Chen J.M., Choudhri A.F., et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 (1998) 973-980
25. Tuman K.J., McCarthy R.J., O'Connor C.J., et al. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 80 (1995) 473-479
26. Oh Y.J., Lee J.H., Nam S.B., et al. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br J Anaesth 97 (2006) 792-798
27. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997) 1122-1125
28. Morales D.L., Gregg D., Helman D.N., et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 69 (2000) 102-106
29. Argenziano M., Choudhri A.F., Oz M.C., et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 96 (1997) 286-290
30. Morales D.L., Garrido M.J., Madigan J.D., et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 75 (2003) 926-930
31. Morales D., Madigan J., Cullinane S., et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100 (1999) 226-229
32. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25 (1997) 1279-1282
33. Peach M.J., Cline W.H., and Watts D.T. Release of adrenal catecholamines by angiotensin II. Circ Res 19 (1966) 571-575
34. Khairallah P.A. Action of angiotensin on adrenergic nerve endings: Inhibition of norepinephrine reuptake. Fed Proc 31 (1972) 1351-1357
35. Giudicelli J.F., Berdeaux A., Edouard A., et al. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol 20 (1985) 211-218
36. Smiley R.M., Pantuck C.B., Chadburn A., et al. Downregulation and desensitization of the beta-adrenergic receptor system of human lymphocytes after cardiac surgery. Anesth Analg 77 (1993) 653-661
37. Hedner J., Towle A., Saltzman L., et al. Changes in plasma atrial natriuretic peptide immunoreactivity in patients undergoing coronary artery bypass graft placements. Regul Pept 17 (1987) 151-157
38. Pigott D.W., Nagle C., Allman K., et al. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth 83 (1999) 715-720
39. Carrel T., Englberger L., Mohacsi P., et al. Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance. J Card Surg 15 (2000) 347-353
40. Salzman A.L., Vromen A., Denenberg A., et al. K(ATP)-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock. Am J Physiol 272 (1997) H688-H694
41. Landry D.W., and Oliver J.A. The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89 (1992) 2071-2074
42. Howl J., and Wheatley M. Molecular pharmacology of V1a vasopressin receptors. Gen Pharmacol 26 (1995) 1143-1152
43. Kusano E., Tian S., and Umino T. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells. J Hypertens 15 (1997) 627-632
44. Levin R.L., Degrange M.A., Bruno G.F., et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77 (2004) 496-499
45. Talbot M.P., Tremblay I., Denault A.Y., et al. Vasopressin for refractory hypotension during cardiopulmonary bypass. J Thorac Cardiovasc Surg 120 (2000) 401-402
46. Licker M., and Schweizer A. Vasopressin and postcardiopulmonary bypass refractory hypotension. Anesth Analg 88 (1999) 695
47. Overand P.T., and Teply J.F. Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass. Anesth Analg 86 (1998) 1207-1209
48. Argenziano M., Chen J.M., Cullinane S., et al. Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant 18 (1999) 814-817
49. Albright T.N., Zimmerman M.A., and Selzman C.H. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care 11 (2002) 326-330
50. Rosenzweig E.B., Starc T.J., Chen J.M., et al. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 100 (1999) II182-II186
51. Dunser M.W., Mayr A.J., Ulmer H., et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 93 (2001) 7-13
52. Patel B.M., Chittock D.R., Russell J.A., et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582